“Phal-501 can be a great drug that has the potential to change the lives of many patients with severe COPD.”

Phal-501 provides a strong and long-lasting binding of mercury and probably also lead and cadmium. Furthermore, Phal-501 is inert (non-reactive) and is therefore not expected to break down or change during passage through the body. Phal-501 has very strong heavy metal binding properties, while the side effects are expected to be very small, if any, as the substance never enters the bloodstream. After swallowing, Phal-501 binds heavy metals in the intestine and then goes directly into the stool. This allows the body’s heavy metals to be “leached out” and rendered harmless.